1. Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties
   Lisa Bierbaumer et al, 2018, Tissue Barriers CrossRef
2. Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition
   Takaaki Oba et al, 2018, Oncotarget CrossRef
3. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage
   Mayuko Hira-Miyazawa et al, 2017, International Journal of Oncology CrossRef
4. The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential
   Xiang Meng et al, 2021, Cancer Communications CrossRef
5. Silencing Neuropilin 1 gene reverses TGF-β1-induced epithelial mesenchymal transition in HGC-27 gastric cancer cell line*
   Weiguo Xu et al, 2020, Oncology and Translational Medicine CrossRef
6. Selectively high efficacy of eribulin against high‑grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck
   Yutaka Kobayashi et al, 2019, Oncology Letters CrossRef
7. Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancer
   Radhika R. Gudi et al, 2021, Oncotarget CrossRef
8. A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition
   Penghui Hu et al, 2022, International Journal of Immunopathology and Pharmacology CrossRef
9. Multiple modes of action of eribulin mesylate: Emerging data and clinical implications
   Javier Cortes et al, 2018, Cancer Treatment Reviews CrossRef
10. The potential influence of long non‐coding RNA PRKG1‐AS1 on oral squamous cell carcinoma: A comprehensive study based on bioinformatics and in vitro validation
    Ting Wu et al, 2020, Journal of Oral Pathology & Medicine CrossRef
11. Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial–mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro
    Gennaro Altamura et al, 2024, Veterinary and Comparative Oncology CrossRef
12. Systematic Analysis of Genetic and Pathway Determinants of Eribulin Sensitivity across 100 Human Cancer Cell Lines from the Cancer Cell Line Encyclopedia (CCLE)
    Pallavi Sachdev et al, 2022, Cancers CrossRef
13. Effect of eribulin on epithelial–mesenchymal transition plasticity in metastatic breast cancer: An exploratory, prospective study
    Takanori Hayashi et al, 2023, Genes to Cells CrossRef
14. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab
    Toshifumi Fujiwara et al, 2018, Oral Oncology CrossRef
15. Approaches for Head and Neck Cancer Research – Current Status and the Way Forward
    Barghavi V. et al, 2022, Cancer Investigation CrossRef
16. Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models
    Songji Zhao et al, 2019, EJNMMI Research CrossRef